What are the safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939 in healthy male subjects?
Single doses of the oral direct factor Xa inhibitor BAY 59-7939 are well tolerated with predictable pharmacokinetics and pharmacodynamics in healthy males.
BAY 59--7939 was well tolerated with predictable pharmacodynamics and pharmacokinetics across a wide range of doses in healthy male subjects. BAY 59--7939 was shown to be an effective and specific factor Xa inhibitor.
Kubitza et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: